Search Results - Kadatz, Matthew J

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    The Benefits of Preemptive Transplantation Using High-Kidney Donor Profile Index Kidneys

    The Benefits of Preemptive Transplantation Using High-Kidney Donor Profile Index Kidneys by Kadatz, Matthew J, Gill, Jagbir, Gill, Justin, Lan, James H, McMichael, Lachlan C, Chang, Doris T, Gill, John S

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    A Phase 1b, Multicenter, Open-Label Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Tegoprubart (AT-1501) in Patients Undergoing Kidney Transplant: PUB299

    A Phase 1b, Multicenter, Open-Label Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Tegoprubart (AT-1501) in Patients Undergoing Kidney Transplant: PUB299 by Tchervenkov, Jean, Coates, Patrick T., Kadatz, Matthew J., Bornstein, Jeffrey D., Gill, John S.

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    A Mate Kidney Analysis to Determine the Impact of Preemptive Transplantation on Outcomes of High Kidney Donor Profile Index Deceased Donor Transplants: TH-OR60

    A Mate Kidney Analysis to Determine the Impact of Preemptive Transplantation on Outcomes of High Kidney Donor Profile Index Deceased Donor Transplants: TH-OR60 by Gill, Justin, Kadatz, Matthew J., Lan, James H., Chang, Doris Tung, Gill, John S., Gill, Jagbir

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Economic Evaluation of the MENTOR Trial Comparing Rituximab and Cyclosporine for the Treatment of Membranous Nephropathy (MN): PO1652

    Economic Evaluation of the MENTOR Trial Comparing Rituximab and Cyclosporine for the Treatment of Membranous Nephropathy (MN): PO1652 by Kadatz, Matthew J., Klarenbach, Scott, So, Helen, Fervenza, Fernando C., Cattran, Daniel C., Barbour, Sean

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Rituximab or cyclosporine A for the treatment of membranous nephropathy: economic evaluation of the MENTOR trial

    Rituximab or cyclosporine A for the treatment of membranous nephropathy: economic evaluation of the MENTOR trial by Kadatz, Matthew, Klarenbach, Scott, So, Helen, Fervenza, Fernando C, Cattran, Daniel C, Barbour, Sean J

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: